>

       

 

ABOUT MEDIPIN®

 

Medipin represents a new and unique dedicated single use precision technology designed to enhance cutaneous pinprick testing in the primary care setting.

 

The instrument consists of a short faceted point, acutely delineated by its surfaces and edges and inclined to stretch rather than penetrate the skin surface, within an annular apparatus that encircles the point with a perimeter of dull stimulation.

 

 

By stretching the skin and contrasting the sharp stimulus of this highly demarcated point with that of the annulus, it is possible to emphasize the neurological phenomenon of Lateral Inhibition where functional connections are formed in the Central Nervous System to highlight differences between areas of sensation.

 

At each application Medipin generates a focussed and well-defined 'Centre Surround' field effect, which augments the acuity of pinprick stimulation and is designed to achieve ‘c’fibre stimulation. The annulus also serves to standardise point penetration and improve test consistency.

 

In short the combination of acuity and reproducibility enhances test sensitivity. This high sensitivity also means less application pressure is required to cause stimulation than in regular devices and the limitation to point penetration provided by the annulus renders cross infection from accidental liberation of bodily fluids significantly less likely.

Medipin has been evaluated and approved by the following institutions:

Manchester Royal Infirmary, UK
Dept of Neurophysiology, National Hospital for Neurology and Neurosurgery, UK
Charing Cross Neurology Department, UK
Harvard Medical School, USA
John Radcliffe Hospital, Oxford, UK
Cornell University Medical College, New York, USA
New York University Medical Centre, New York, USA

 

 

Medipin’s Design Promotes

 

·       NEUROPHYSIOLOGICALLY ENHANCED PINPRICK STIMULUS FOR EARLIER DIAGNOSIS AT CLINICALLY SIGNIFICANT THRESHOLDS.

 

·       CONSISTENTLY SUPERIOR STIMULATION AT REDUCED APPLICATION PRESSURES EVEN IN EXISTING NEUROPATHY.

 

·       EXAMINATION TO TARGET CRITICAL ‘A∂’ and ‘C’ NERVE FIBRES.

 

·       INFECTION CONTROL AUGMENTATION BY INHIBITING PENETRATION OF POINT.

 

 

 

MENU

click to navigate

Home

 

Advantages

 

About

 

Instructions for use

 

The Argument

 

Endorsements

 

Purchase Medipin®

© Medipin 2005  Hi-Tech Web Design